Sort   by:  
 Page size 
UnknownPolymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients.
Not available
S-EPMC3956729 | biostudies-literature
UnknownBortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naive or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial.
Not available
S-EPMC3502148 | biostudies-literature
UnknownHigher genome variability within metabolism genes associates with recurrent Clostridium difficile infection.
Not available
S-EPMC7842062 | biostudies-literature
UnknownConditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network.
Not available
S-EPMC11739754 | biostudies-literature
UnknownEscherichia coli Genomic Diversity within Extraintestinal Acute Infections Argues for Adaptive Evolution at Play.
Not available
S-EPMC7845604 | biostudies-literature
UnknownProspective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.
Not available
S-EPMC5814930 | biostudies-literature
UnknownBrentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Not available
S-EPMC6436818 | biostudies-literature
UnknownCirculating tumor-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress anti-tumor immunity in patients with melanoma.
Not available
S-EPMC12285569 | biostudies-literature
UnknownBrentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Not available
S-EPMC5819601 | biostudies-literature
Sort   by:  
 Page size